These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16709180)

  • 1. Developing chemokine mutants with improved proteoglycan affinity and knocked-out GPCR activity as anti-inflammatory recombinant drugs.
    Potzinger H; Geretti E; Brandner B; Wabitsch V; Piccinini AM; Rek A; Kungl AJ
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):435-7. PubMed ID: 16709180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biological relevance of chemokine-proteoglycan interactions.
    Proudfoot AE
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):422-6. PubMed ID: 16709177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering the glycosaminoglycan-binding affinity, kinetics and oligomerization behavior of RANTES: a tool for generating chemokine-based glycosaminoglycan antagonists.
    Brandner B; Rek A; Diedrichs-Möhring M; Wildner G; Kungl AJ
    Protein Eng Des Sel; 2009 Jun; 22(6):367-73. PubMed ID: 19414521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins.
    Lau EK; Allen S; Hsu AR; Handel TM
    Adv Protein Chem; 2004; 68():351-91. PubMed ID: 15500866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in chemokines and chemokine receptors.
    Zlotnik A; Morales J; Hedrick JA
    Crit Rev Immunol; 1999; 19(1):1-47. PubMed ID: 9987599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of chemokine-glycosaminoglycan interaction specificity.
    Kawashima H
    Methods Enzymol; 2006; 416():254-63. PubMed ID: 17113871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.
    Proudfoot AE; Handel TM; Johnson Z; Lau EK; LiWang P; Clark-Lewis I; Borlat F; Wells TN; Kosco-Vilbois MH
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1885-90. PubMed ID: 12571364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of posttranslational processing on the in vitro and in vivo activity of chemokines.
    Mortier A; Gouwy M; Van Damme J; Proost P
    Exp Cell Res; 2011 Mar; 317(5):642-54. PubMed ID: 21146523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-encoded chemokine receptors--putative novel antiviral drug targets.
    Rosenkilde MM
    Neuropharmacology; 2005 Jan; 48(1):1-13. PubMed ID: 15617722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of chemokine activity by posttranslational modification.
    Mortier A; Van Damme J; Proost P
    Pharmacol Ther; 2008 Nov; 120(2):197-217. PubMed ID: 18793669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
    Carter PH; Tebben AJ
    Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of protein function by glycosaminoglycans--as exemplified by chemokines.
    Handel TM; Johnson Z; Crown SE; Lau EK; Proudfoot AE
    Annu Rev Biochem; 2005; 74():385-410. PubMed ID: 15952892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology.
    Navratilova I; Dioszegi M; Myszka DG
    Anal Biochem; 2006 Aug; 355(1):132-9. PubMed ID: 16762304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonistic and antagonistic activities of chemokines.
    Loetscher P; Clark-Lewis I
    J Leukoc Biol; 2001 Jun; 69(6):881-4. PubMed ID: 11404371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine receptor-derived peptides as multi-target drug leads for the treatment of inflammatory diseases.
    Ezerzer C; Dolgin M; Skovorodnikova J; Harris N
    Peptides; 2009 Jul; 30(7):1296-305. PubMed ID: 19540428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling the mechanisms underpinning chemokine receptor activation and blockade by small molecules: a fine line between agonism and antagonism?
    Wise E; Pease JE
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):755-9. PubMed ID: 17635141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy.
    Ali S; O'Boyle G; Mellor P; Kirby JA
    Mol Immunol; 2007 Mar; 44(7):1477-82. PubMed ID: 17000001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of chemokines in ocular diseases. Part II. Participation of chemokines in ocular diseases].
    Malesiński R; Mrugacz M; Bakunowicz-Łazarczyk A
    Klin Oczna; 2007; 109(7-9):345-8. PubMed ID: 18260295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics.
    Suresh P; Wanchu A
    J Postgrad Med; 2006; 52(3):210-7. PubMed ID: 16855325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity.
    Gerlza T; Winkler S; Atlic A; Zankl C; Konya V; Kitic N; Strutzmann E; Knebl K; Adage T; Heinemann A; Weis R; Kungl AJ
    Protein Eng Des Sel; 2015 Aug; 28(8):231-40. PubMed ID: 25969511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.